GLOW is sold as a skin blend, and it's three compounds: GHK-Cu, BPC-157 and TB-500. Two of those three are systemic tissue-repair compounds with essentially no skin case of their own. The third, GHK-Cu, is the one the skin claims belong to, and it's also the one most commonly used on skin rather than injected into a stomach. So the honest description of GLOW is a repair stack with a skin compound in it, sold under the skin compound's name.
Vial size isn't part of what follows, since the amount of bacteriostatic water you add sets your concentration either way. Our reconstitution calculator handles that math for whatever vial and target amount you're working with.
What it is
Three compounds in one vial, and they are not equal partners.
GHK-Cu is a copper-carrying tripeptide, and it's the skin one. It has the most direct evidence of the three for collagen production and skin remodelling, and it's the reason this blend is marketed the way it is.
BPC-157 and TB-500 are the pair sold elsewhere as the Wolverine blend, for tendons, ligaments and general tissue repair. Their research is in injury models, not in skin.
What's actually in the vial. The 70 mg size that most vendors sell is not 70 mg of a single thing, and it isn't equal thirds either. The conventional split puts around 50 mg of GHK-Cu with about 10 mg each of the other two, which means roughly seven tenths of what you're buying by weight is the copper peptide. That's worth knowing when comparing a GLOW vial against a plain GHK-Cu vial, because the comparison people usually make assumes the blend is three compounds' worth of value.
What people use it for
Skin, and specifically the midlife version: thinning, laxity, texture that changed somewhere around the menopause transition and hasn't changed back. GHK-Cu's research is genuinely about collagen and dermal remodelling, so the target and the compound match.
Hair comes up frequently as a second reason, resting on GHK-Cu's copper chemistry and follicle work.
Recovery is the third, and this is where the other two compounds earn their place. If you want skin and you have a shoulder that's been annoying you since spring, the blend is doing two jobs. If you only want skin, you're paying for a repair stack you didn't need.
Formulations
Sold as premixed lyophilized powder, and the market has consolidated hard on one size: 70 mg vials from most vendors we track, with a handful offering 10 mg or 50 mg.
Injected is not the only option for the skin component, and arguably not the obvious one. GHK-Cu is widely used topically, in creams and serums, and topical is how most of its skin research was done. Injecting a systemic dose to reach the skin is a longer route to the same tissue. People do both, and some reconstitute a blend vial and use part of it topically, which is improvisation rather than protocol.
Dosing protocols
No approved product exists for any of the three, so everything below is convention. As with every blend, one draw gives you all three in whatever proportion the vendor chose.
See the GLOW blend research notes for the research on each component.
| Pattern | Amount | How often | Where it comes from |
|---|---|---|---|
| Most commonly referenced | 1–2 mg total blend | Once daily | The circulating convention, repeated across vendor education pages with no named source. On the usual split that delivers roughly 700 mcg to 1.4 mg of GHK-Cu per dose. |
| Five on, two off | 1–2 mg total blend | Five consecutive days, then two off | A cost and tolerance pattern, with nothing published behind it. |
| Topical, for the skin component | Not established for a blend | — | GHK-Cu's own skin research was largely topical, and purpose-made topical products exist at known concentrations. A reconstituted blend applied to skin is neither of those things and no concentration is established for it. |
| What research established | Nothing, for this blend | — | Each compound has its own research and the three-way combination has never been studied in anything. GHK-Cu's skin evidence is largely topical; BPC-157 and TB-500's research is animal injury work, not skin. |
Injected patterns above are subcutaneous.
What one draw actually delivers
Because the split isn't even, the arithmetic is worth doing once. On a 70 mg vial holding roughly 50 mg GHK-Cu and 10 mg each of the other two, reconstituted with 3 mL of bacteriostatic water, you have about 23,300 mcg per mL of total material. A 1.5 mg draw is 0.064 mL, or about 6 units on a standard U-100 insulin syringe, and it delivers roughly 1,070 mcg of GHK-Cu with about 215 mcg each of BPC-157 and TB-500.
Compare that last figure against the separate-vial conventions and something becomes clear: 215 mcg of BPC-157 is at the bottom of its usual 250 to 500 mcg range, and 215 mcg of TB-500 is a small fraction of the 2 to 5 mg its own convention describes. So if you're taking GLOW hoping to also treat an injury, the repair half is arriving at a fraction of what people run for that purpose. It isn't a Wolverine stack with skin benefits; it's a GHK-Cu protocol with a trace of the other two.
Amount total, for planning your purchase. At 1.5 mg of blend daily, a 70 mg vial is about 46 days. That's a long-lived vial and it collides with the reconstituted window below.
How much to reconstitute at once. A reconstituted vial keeps about 28 days refrigerated, and daily dosing at 1.5 mg only uses about 42 mg in that time, so a full 70 mg vial leaves roughly 28 mg to expire. This is one of the clearest cases on the site for mixing part of a vial rather than all of it. See how much to reconstitute at once for the general math.
Cycling guidelines
Eight to twelve weeks on with a break after is the pattern described most often, and nothing establishes it. Skin changes are slow, so shorter runs are unlikely to tell you anything.
One consideration specific to this blend: it delivers copper, in the GHK-Cu. Copper is an essential mineral with a fairly narrow comfortable range, and continuous long-term supplementation of anything copper-bearing is a reasonable thing to break from even though nobody has studied whether these amounts accumulate meaningfully.
Signs a course is commonly stopped or reconsidered:
- Injection site reactions, which are more commonly reported with copper-containing compounds than with most peptides
- A metallic taste, occasionally described and attributed to the copper
- Nausea or headache in the first week
- Twelve weeks with no visible change, which is the point at which skin should have shown something if it were going to
Stacking
This is a three-compound stack already, and the honest advice is to add nothing.
Where KPV comes up: adding it turns GLOW into KLOW, which is sold as its own product. The rationale is inflammation control alongside repair, which is a different job from the other three and so at least isn't redundant.
Where a topical goes: alongside rather than instead. People commonly run the injected blend and use a purpose-made topical GHK-Cu product on their face, which is a reasonable way to get the skin compound to the skin by the route its research actually used.
Combinations to approach carefully: other copper-containing products, including AHK-Cu and copper supplements. Copper is the one ingredient here where more is not automatically better and where stacking sources is a real consideration rather than a theoretical one.
Expected results timeline
First weeks: nothing visible. Skin remodels slowly and anything reported in the first fortnight is unlikely to be the compound.
Eight to twelve weeks: where reports cluster, described as texture and firmness rather than lines disappearing. Self-reported and difficult to assess in a mirror you look at daily, which is why before-photographs are worth taking.
Beyond: no data for the blend at any duration.
What to expect realistically: GHK-Cu has the most credible skin research of anything in this market, and most of it is topical rather than injected. The other two compounds in this vial have essentially nothing to do with skin. So the reasonable expectation is roughly whatever GHK-Cu would give you, delivered by a route its research mostly didn't use, at a price that also buys two compounds arriving in trace amounts.
Administration technique
- The lyophilized powder is reconstituted with bacteriostatic water. For a 70 mg vial, 3 mL is a common choice and keeps the draw at a manageable size.
- The solution is swirled gently to dissolve rather than shaken. GHK-Cu gives the solution a distinct blue tint, which is normal and is the copper.
- The vial is commonly labelled with the date and the concentration.
- The calculated volume is drawn into an insulin syringe.
- A subcutaneous site is chosen, commonly the abdomen, with sites rotated daily.
- The skin is pinched and the injection given at roughly a 45-degree angle.
- Where a topical GHK-Cu product is used alongside, it's applied to clean skin on its own schedule and isn't a substitute for the injected amount, or vice versa.
Side effects and safety
Common: injection site reactions, reported more often with copper-containing compounds than with most peptides on this site. A metallic taste occasionally.
Less common: nausea and headache early in a course.
What we don't know: everything about the combination, which has never been studied. For the components: GHK-Cu's skin research is largely topical and largely not in the form of long-term injected use; BPC-157 and TB-500 have essentially no human safety data at any amount.
The theoretical concern worth naming: two of the three compounds encourage new blood vessel growth, which is also what a tumour requires. Nothing establishes a risk and nothing rules it out, and anyone with a cancer history should treat that as a conversation with a clinician rather than a line to skim.
Contraindications: active cancer, on the reasoning above. Wilson's disease or any condition affecting copper handling, given the copper content. Pregnancy, breastfeeding and use in minors have no data.
Drug interactions: none established. Other copper sources are the practical consideration.
GLOW vs. GHK-Cu on its own
Since GHK-Cu is both the skin component and most of the vial by weight, the real question isn't which blend to buy, it's whether you need a blend at all.
| GLOW blend | GHK-Cu alone | |
|---|---|---|
| Skin evidence | Comes entirely from the GHK-Cu in it | The same evidence, undiluted by anything else |
| What else you get | BPC-157 and TB-500, in trace amounts relative to their own conventions | Nothing else |
| Topical option | Improvised at an unknown concentration | Purpose-made topical products exist at known strengths |
| Best if | You want skin and general repair together and accept both arrive partly dosed | Skin is the actual goal |
Choose GLOW if: you genuinely want both skin and tissue repair, and you'd rather have one injection than three.
Choose GHK-Cu alone if: skin is what you're after. It's the component with the evidence, and buying it alone lets you use it topically, which is how most of that evidence was generated.
See the GHK-Cu guide and protocols for its own dosing, and the Wolverine blend guide if the repair half is what you actually want.
Storage and handling
Lyophilized powder: refrigerate at 2 to 8°C and protect from light; frozen for longer storage, which matters here given how long a 70 mg vial lasts.
Reconstituted solution: refrigerate and use within about 28 days. Three peptides share this solution and there's no reason to assume they degrade at the same rate, so plan around the shortest window rather than the longest. The blue tint from the copper is normal; a change in it is not.
Signs of degradation:
- Cloudiness or visible particles in a solution that was previously clear
- A shift in the blue colour, which is more legible on this blend than on most
- Powder that has clumped or gone sticky
FAQ
What's in a 70 mg vial? Conventionally around 50 mg of GHK-Cu with about 10 mg each of BPC-157 and TB-500, so roughly seven tenths GHK-Cu by weight. Confirm with the vendor, since splits vary.
Why is the solution blue? The copper in GHK-Cu. It's normal, and a change in the colour is a useful degradation signal.
Should I inject it or put it on my face? GHK-Cu's skin research is largely topical, and purpose-made topical products exist at known concentrations. A reconstituted blend applied to skin is neither.
Do I get a proper repair dose from the blend? No. At a typical draw the BPC-157 arrives at the bottom of its own range and the TB-500 at a small fraction of its own. It isn't a substitute for the Wolverine stack.
GLOW or plain GHK-Cu? Plain GHK-Cu if skin is the goal. GLOW if you want the repair compounds too and accept they arrive lightly dosed.
How long before I'd see anything? Eight to twelve weeks, and take before-photographs, because skin changes slowly and you look at your own face too often to judge it.
Can I take it with a copper supplement? That's the one interaction worth thinking about. Copper is essential, has a fairly narrow comfortable range, and this blend is a copper source.
How much should I reconstitute? Less than the whole vial. At daily dosing a 70 mg vial lasts around 46 days and the reconstituted window is about 28.
Bottom line
Key dosing takeaways:
- 1 to 2 mg of total blend daily is the circulating convention, with no source behind it
- A 70 mg vial is roughly seven tenths GHK-Cu, so most of what you're buying is the skin compound
- The repair compounds arrive at a fraction of their own conventional amounts, so this is not a Wolverine stack with a skin bonus
Best practices:
- Reconstituting part of the vial rather than all of it, since 70 mg outlasts the 28-day window at daily dosing
- Using a purpose-made topical GHK-Cu product if skin is the target, since that's the route its research used
- Taking before-photographs, because skin change is slow and self-assessment is unreliable
Works best for people who:
- Want skin and general repair at once and would rather not run three separate compounds
- Understand they are mostly buying GHK-Cu
- Have no copper-handling condition and aren't stacking other copper sources
Every compound in this blend is sold for research, and the three-way combination has never been studied in anything. You already know that. You're an adult making an informed call about your own body, and that's yours to make.